Cadrenal Therapeutics, Inc. · NASDAQ:CVKD

PNC Financial Services Group, Inc. reported a 8.13% stake in Cadrenal Therapeutics, Inc. (Schedule 13G)

Event Jun 30, 2026 · Filed Aug 7, 2026

PNC Financial Services Group, Inc. reported a 8.13% stake in Cadrenal Therapeutics, Inc., 233,219 shares, as a passive investor on Jun 30, 2026. Filed Aug 7, 2026 (Schedule 13G).

Stake
8.13%
Shares
233,219
Intent
Passive
What changed
Crossed above 5%

The filing in full

HolderStakeShares
The PNC Financial Services Group, Inc.8.13%233,219

Source

View original at SEC

Related